Biofil Chemicals & Pharmaceuticals (BOM:524396) COGS-to-Revenue : 0.89 (As of Dec. 2023)

Biofil Chemicals & Pharmaceuticals COGS-to-Revenue Chart

Biofil Chemicals & Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
COGS-to-Revenue		Get a 7-Day Free Trial					0.86	0.85	0.91	0.89	0.93

Biofil Chemicals & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.64	0.97	0.71	0.97	0.89

Biofil Chemicals & Pharmaceuticals COGS-to-Revenue Calculation

Biofil Chemicals & Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Biofil Chemicals & Pharmaceuticals's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals  (BOM:524396) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biofil Chemicals & Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biofil Chemicals & Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description